Author Archives: donttradeourlivesaway

Drug Prices Can Take A Surprising Turn When A Poor Country Gets Richer

Source: National Public Radio 9th July, 2019       When a poor country becomes wealthier, it’s a good thing, right? Not if the country is trying to buy essential medicines. A new report, published by the Center for Global Development in … Continue reading

Posted in Drug prices | Leave a comment

“Delinkage” Of Medicines R&D From Patent Incentives Stirs Debate at Human Rights Council

Source: Health Policy Watch 9th July, 2019   Only a month after a hotly-contested World Health Assembly resolution touched off a debate around “price transparency” as a way to improve access to medicines, a new controversy over how to stimulate access has emerged … Continue reading

Posted in Delinkage, Patent, R&D, Uncategorized | Leave a comment

Sen. Josh Hawley on the push for data transparency in new bill

Source: CNBC 28th June, 2019   Sen. Josh Hawley (R-Mo.) joins “Squawk Alley” to discuss the new bipartisan bill he introduced with Sen. Mark Warner (D-Va.) to make Big Tech’s use of user data more transparent.  

Posted in Transparency | Leave a comment

Trump Administration Pushes To Make Health Care Pricing More Transparent

Source: National Public Radio 28th June, 2019   The executive order on drug price transparency that President Trump signed Monday doesn’t spell out specific actions; rather, it directs the department of Health and Human Services to develop a policy and then … Continue reading

Posted in Price Transparency, Transparency | Leave a comment

Drug price promise ‘falter’

Source: Telegraph India 28th June, 2019   Cryptococcal meningitis kills an estimated 180,000 people every year, over three-fourths of them in sub-Saharan Africa Pathogenic yeast fungus Cryptococcus neoformans causes meningoencephalitis in patients with AIDS.(Shutterstock: 3D illustration) The US-based pharmaceutical company Gilead … Continue reading

Posted in Drug prices | Leave a comment

Gilead’s HIV drug remains costly despite the company’s promise to slash its price

Source: The Hindu Business Line 28th June, 2019   Government force to opt for cheaper medicines with side-effects, says MSF US pharmaceutical firm Gilead is not living up to its promise of supplying the life-saving anti-fungal drug liposomal amphotericin B (LAmB) … Continue reading

Posted in Drug prices, HIV/Aids | Leave a comment

Price transparency is exactly what the doctor ordered

Source: Washington Examiner 28th June, 2019   On behalf of doctors across America and their patients, I am writing to underscore the importance of the executive order President Trump signed this week on “Improving Price and Quality Transparency in Healthcare.” Everyone … Continue reading

Posted in Price Transparency, Price Transparency | Leave a comment